Medical Doctor Program year 2023 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Stephen Blank

Obstetrics & Gynecology Atlanta, GA Medical Doctor

NPI 1619902293 CMS profile 164184

755 Mount Vernon Hwy Ne, #330, Atlanta, GA 30328

Open in the dashboard

General payments

$15,221

80 records reported · program years 2019–2023

Research payments

$1,224

Paid to them · 15 records reported · program years 2019–2023

Ownership & investment interest

$5

5 holdings reported · through program year 2023

Research they led as principal investigator

$3,450,975 paid to institutions, not to them · program years 2019–2025

Through program year 2023, Stephen Blank of Atlanta, GA is reported in the CMS Open Payments database as having received $15,221 across 80 general payments and $1,224 in research payments paid to them. Separately, studies naming them as principal investigator received $3,450,975 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $5 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $4,860 26
2022 General $235 16
2021 General $318 13
2020 General $131 8
2019 General $9,677 17
2019 Research $1,224 15
2024 Ownership $1 1
2023 Ownership $1 1
2022 Ownership $1 1
2021 Ownership $1 1
2020 Ownership $1 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Blank
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Stephen Blank were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Stephen Blank Obstetrics & Gynecology median Middle half National median
2019 $9,677 $172 $62–$391 $163
2020 $131 $94 $36–$222 $114
2021 $318 $136 $42–$369 $132
2022 $235 $160 $50–$433 $149
2023 $4,860 $169 $56–$423 $160
2024 $0 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Lupin Inc. $9,279 5 payments
  2. Moderna TX, Inc. $2,958 12 payments
  3. Boehringer Ingelheim International GmbH $1,803 13 payments
  4. AbbVie, Inc. $355 15 payments
  5. Pfizer Inc. $208 16 payments
  6. Covidien LP $156 3 payments
  7. TherapeuticsMD, Inc. $131 2 payments
  8. AstraZeneca Pharmaceuticals LP $99 1 payment
  9. SCYNEXIS, Inc. $49 2 payments
  10. Amgen Inc. $48 3 payments
  11. Other $135 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,087 2 payments
  2. Travel and Lodging $3,215 14 payments
  3. Food and Beverage $2,901 63 payments
  4. Education $17 1 payment
Products named General payments · program years 2019–2023
  1. SOLOSEC $9,279 5 payments
  2. Orilissa Endocrinology $183 5 payments
  3. MYFEMBREE $165 13 payments
  4. TruClear $156 3 payments
  5. ORILISSA Womens Health $128 8 payments
  6. ANNOVERA $114 1 payment
  7. BIJUVA $114 1 payment
  8. IMVEXXY $114 1 payment
  9. CALQUENCE $99 1 payment
  10. ORIAHNN $99 6 payments
  11. Other $549 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. GlaxoSmithKline, LLC. $1,224 15 payments

Records

95 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record